OR WAIT null SECS
February 05, 2024
An analysis of the two main new models for pharmacy—unique direct—to-consumer for brands and cash pay for generics—and what members of industry think about them.
February 02, 2024
Leading experts in the sector explore the value of third-party logistics providers when it comes to fortifying pharmaceutical supply chains.
February 01, 2024
Duplicate rebates have resulted in revenue leakage for manufacturers.
January 31, 2024
As a result, time to treatment for the brand Gilead product is expected to increase from 16 to 14 days.
The pharmaceutical packaging company unveils a new siliconization line at its SQLM plant in France.
January 30, 2024
The latest financial commitment adds 24,000 liters of biologics drug substance-capacity to the company’s network.
January 26, 2024
The Identification of Medicinal Product framework seeks to establish a common language for identifying, documenting, and exchanging information about medicinal products.
January 23, 2024
Acquisition is expected to strengthen company’s CDMO business, while establishing a footprint in the generics space.
January 15, 2024
Roots Analysis report suggests increase can be attributed to the growing demand for advanced therapies and biologics.
January 11, 2024
Manufacturers should leverage the knowledge base of personnel working in sterility assurance and in microbiology laboratories.